verapamil has been researched along with Cognitive Dysfunction in 3 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
Cognitive Dysfunction: Diminished or impaired mental and/or intellectual function.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Oral treatment with verapamil or vehicle was started, 24 h post-intracerebroventricular (ICV) streptozotocin/(STZ), in 12-month-old animals and continued for 3 months." | 1.62 | Verapamil Prevents Development of Cognitive Impairment in an Aged Mouse Model of Sporadic Alzheimer's Disease. ( Ahmed, HA; Ishrat, T; Ismael, S; Mirzahosseini, G, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, HA | 1 |
| Ismael, S | 1 |
| Mirzahosseini, G | 1 |
| Ishrat, T | 1 |
| Yu, H | 1 |
| Li, M | 1 |
| Shen, X | 1 |
| Lv, D | 1 |
| Sun, X | 1 |
| Wang, J | 1 |
| Gu, X | 1 |
| Hu, J | 1 |
| Wang, C | 1 |
| Hwang, JJ | 1 |
| Sherwin, RS | 1 |
3 other studies available for verapamil and Cognitive Dysfunction
| Article | Year |
|---|---|
Verapamil Prevents Development of Cognitive Impairment in an Aged Mouse Model of Sporadic Alzheimer's Disease.
Topics: Aging; Alzheimer Disease; Animals; Brain; Calcium Channel Blockers; Cognitive Dysfunction; Disease M | 2021 |
The Requirement of L-Type Voltage-Dependent Calcium Channel (L-VDCC) in the Rapid-Acting Antidepressant-Like Effects of Scopolamine in Mice.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Brain-Derived Neurotrophic Factor; Calcium Channel | 2018 |
Verapamil is a potential therapy for hypoglycaemic brain injury.
Topics: Brain; Brain Injuries; Cognitive Dysfunction; Humans; Hypoglycemia; Hypoglycemic Agents; Verapamil | 2018 |